Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Obstructive Lung Diseases

Free Subscription 10.11.2025 3 Allergy 1 Ann Allergy Asthma Immunol 3 Arch Bronconeumol 4 Eur Respir J 1 J Allergy Clin Immunol 4 J Asthma 1 J Investig Allergol Clin Immunol 2 Pediatr Allergy Immunol 2 PLoS One 1 Respir Med 2 Respir Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Allergy

1. KIM MJ, Lee SH, Kim SJ, Song HE, et al
   Association Between Di-(2-Ethylhexyl) Phthalate and Childhood Asthma Through Plasma Metabolome Alterations.
   Allergy. 2025 Nov 3. doi: 10.1111/all.70143.
   PubMed        
   
   
2. ASAMOAH K, Yang F, Adcock IM, Vuckovic D, et al
   Trajectory-Based Clustering to Identify Asthma Subgroups Responsive to the Selective CXCR2 Antagonist, AZD5069.
   Allergy. 2025 Nov 2. doi: 10.1111/all.70140.
   PubMed        
   
   
3. PARK SO, Uyangaa E, Kim HJ, Byeon HW, et al
   Myeloid cAMP Reduction Shifts Rhinovirus-Induced Airway Inflammation From Neutrophilic to Eosinophilic by Suppressing M1-Interstitial Macrophages.
   Allergy. 2025;80:3055-3076.
   PubMed         Abstract available
   
   

   
   Ann Allergy Asthma Immunol

4. NARLA S, Silverberg JI
   Current updates in the epidemiology and comorbidities of atopic dermatitis.
   Ann Allergy Asthma Immunol. 2025 May 9:S1081-1206(25)00228.
   PubMed         Abstract available
   
   

   
   Arch Bronconeumol

5. SOLARAT B, Mendoza N, Perea L, Amaro R, et al
   Systemic Immune Dysregulation in Patients With Bronchiectasis and Chronic Pseudomonas aeruginosa Infection.
   Arch Bronconeumol. 2025 Oct 25:S0300-2896(25)00382.
   PubMed        
   
   
6. MCSHANE PJ
   Are Dipeptidyl Peptidase-1 Inhibitors the Future Anti-inflammatory Treatment in Bronchiectasis?
   Arch Bronconeumol. 2025 Sep 12:S0300-2896(25)00312.
   PubMed        
   
   
7. SINGH D, Menendez Lobo A, Higham A, Alcazar Navarrete B, et al
   Biological Therapy in COPD Management: Current Evidence, Challenges and Opportunities.
   Arch Bronconeumol. 2025;61:690-696.
   PubMed         Abstract available
   
   

   
   Eur Respir J

8. HALPIN DM, Masekela R, Vogelmeier CF, Ozoh OB, et al
   Addressing the global challenges of COPD and asthma: a shared vision from the global initiative for chronic obstructive pulmonary disease (GOLD) and the global initiative for asthma (GINA).
   Eur Respir J. 2025 Nov 6:2502244. doi: 10.1183/13993003.02244-2025.
   PubMed        
   
   
9. SIBILA O, Perea L, Aliberti S
   Emerging therapies in bronchiectasis.
   Eur Respir J. 2025 Nov 6:2501309. doi: 10.1183/13993003.01309-2025.
   PubMed        
   
   
10. HANSEN S, von Bulow A, Cooper A, Sandin P, et al
    Mortality in Severe Asthma - results from the NORDSTAR cohort.
    Eur Respir J. 2025 Nov 6:2501289. doi: 10.1183/13993003.01289-2025.
    PubMed         Abstract available
    
    
11. CARLIER FM, Detry B, Ambroise J, Heddebaut N, et al
    Impaired IgA Mucosal Immunity Following Lung Transplantation: A Potential Trigger for Bronchiolitis Obliterans Syndrome.
    Eur Respir J. 2025 May 22:2402212. doi: 10.1183/13993003.02212-2024.
    PubMed         Abstract available
    
    

    
    J Allergy Clin Immunol

12. RURAN HB, Jung YS, Chen Q, Nadeau K, et al
    IL-4 variant and school mouse exposure increases asthma morbidity in urban schoolchildren.
    J Allergy Clin Immunol. 2025 Nov 3:S0091-6749(25)01032.
    PubMed        
    
    

    
    J Asthma

13. LUO J, Meng X, Chen W, Feng F, et al
    Moderating effect of pet ownership in the association between jogging and asthma emergencies: a cross-sectional study based on NHANES III.
    J Asthma. 2025 Nov 1:1-9. doi: 10.1080/02770903.2025.2581002.
    PubMed         Abstract available
    
    
14. YUAN L, Wang L, Zhang L, Liu Y, et al
    Neutrophilic-dominant phenotype during exacerbations predicts adverse hospital outcomes in asthma-bronchiectasis overlap syndrome.
    J Asthma. 2025 Nov 5:1-11. doi: 10.1080/02770903.2025.2577639.
    PubMed         Abstract available
    
    
15. GEMICIOGLU B, Celik G, Damadoglu E, Efe O, et al
    Turkish Language Validity and Reliability of the Severe Asthma Questionnaire (SAQ).
    J Asthma. 2025 Nov 3:1-14. doi: 10.1080/02770903.2025.2583243.
    PubMed         Abstract available
    
    
16. GAO M, Wang X, Yin L, Wei X, et al
    Immunomodulatory Effects of Bacterial Lysates on the IL-17 Signaling Pathway in an Asthma Mouse Model.
    J Asthma. 2025 Nov 4:1-12. doi: 10.1080/02770903.2025.2581003.
    PubMed         Abstract available
    
    

    
    J Investig Allergol Clin Immunol

17. GALVAN CA, Duran R, Quirce S
    A Critical Review of Occupational Asthma in the 21st Century Work Environment.
    J Investig Allergol Clin Immunol. 2025 Nov 5:0. doi: 10.18176/jiaci.1123.
    PubMed         Abstract available
    
    

    
    Pediatr Allergy Immunol

18. JACKSON DJ, Gappa M, Bacharier LB, Deschildre A, et al
    Dupilumab efficacy by disease severity in pediatric type 2 asthma.
    Pediatr Allergy Immunol. 2025;36:e70196.
    PubMed         Abstract available
    
    
19. CRESTANI E, Harb H, Benamar M, Kaddurah-Daouk R, et al
    Metabolomic and immunological signatures of asthma severity in children.
    Pediatr Allergy Immunol. 2025;36:e70242.
    PubMed         Abstract available
    
    

    
    PLoS One

20. JI X, Chen H, He SD, Huang M, et al
    Xiao Qing Long Tang ameliorates neutrophil extracellular trap-dendritic cells-T helper 17 cell axis in Neutrophilic Asthma.
    PLoS One. 2025;20:e0336333.
    PubMed         Abstract available
    
    
21. TAWFIK M, Fathi IS, Nimbhore SS, Alsmadi IM, et al
    E-RespiNet: An LLM-ELECTRA driven triple-stream CNN with feature fusion for asthma classification.
    PLoS One. 2025;20:e0334528.
    PubMed         Abstract available
    
    

    
    Respir Med

22. BERTHON BS, Williams LM, McLoughlin RF, Nichol KS, et al
    Pilot investigation of an oligosaccharide blend in adults with asthma - a double-blind, randomised, placebo-controlled, 4-arm crossover trial.
    Respir Med. 2025 Nov 3:108474. doi: 10.1016/j.rmed.2025.108474.
    PubMed         Abstract available
    
    

    
    Respir Res

23. ABUJABAL R, Alanta TM, Alhamidi RS, Altaie AM, et al
    IL-5 signaling in asthmatic derived fibroblasts exacerbates airway remodeling through ECM dysregulation and apoptosis resistance.
    Respir Res. 2025;26:307.
    PubMed         Abstract available
    
    
24. MARCON A, Martinelli L, Bansal AT, Berret E, et al
    Use of long-acting muscarinic antagonists for severe asthma: insights from clinicians in the SHARP network.
    Respir Res. 2025;26:306.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.